Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


TV400Y - Casting base included for self-cast 20.5 x 20cm gels

Product Description
Scie-Plas TV Range vertical gel electrophoresis units offer the ultimate standards in innovative design and manufacture. The TV Range vertical gel electrophoresis units are available in a variety of different plate sizes for applications ranging from routine SDS-PAGE mini-gels to large format nucleic acid sequencing and single-strand conformational polymorphism (SSCP) studies. As with our Green Range horizontal gel units, each new-style TV Range vertical gel electrophoresis unit incorporates the many design and safety features recommended to us over the years by scientists, either from within our in-house product development team or laboratories worldwide. Accordingly, each unit is manufactured and finished to the highest specification, versatile, easy to use and fully compliant with European safety regulations. The TV Range vertical gel electrophoresis units are available in a range of different formats.

The TV400Y twin-plate 20.5 x 20cm (W x H) maxi-gel unit includes, as standard, a precision engineered casting base, which acts in conjunction with our recently modified TV400-GRM to provide simple, leak-free casting. Triple screws, located on each gel clamp within the GRM, work in tandem with a dovetailed silicone gasket to distribute pressure evenly along the height and breadth of the gel, while glass plate stops lock the glass plates firmly into position on the casting base as the cam pins are turned clockwise through 120°.

FEATURES

Complete System
TV400Y unit with GRM, gel tank, lid, 2 (20.5 x 20cm; W x H) plain glass plates, 4 x 1mm spacers, 2 x spacer aligners, 2 (20.5 x 20cm) notched glass plates, 1 x dummy plate and 2 x 1mm thick 24-sample combs, plus a casting base and 2 x silicone seals
Unit Dimensions (W x D x H): 28.5 x 15 x 27.5cm
Active Gel Dimensions (W x H): 16.5 x 17.5cm
Maximum Sample Capacity: 2 x 48
Recommended Buffer Volume: Inner Buffer Chamber: 700ml; Gel Tank 4200ml
Recommended Power Supplies: Consort EV243
Product TV400Y - Casting base included for self-cast 20.5 x 20cm gels
Company Scie-Plas Ltd
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity 1
Company Logo

Scie-Plas Ltd
22 Cambridge Science Park Milton Road Cambridge CB4 0FJ UK

Tel: +44 (0) 1223 427888
Fax: +44 (0) 1223 420164
Email: Sales@scie-plas.co.uk



Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!